Medical device pricing will be “one of the most important positive narratives” of next year and drive “modest upside” to sales and margins, according to analysts at Goldman Sachs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,